APR 15, 2024 2:58 PM PDT

An AI Breakthrough in Heart Failure Screening

WRITTEN BY: Greta Anne

Heart failure is a prevalent and debilitating condition associated with significant morbidity and mortality worldwide. Timely detection of heart failure, particularly reduced left ventricular ejection fraction (LVEF), is crucial for initiating appropriate management and improving patient outcomes. Traditional methods for assessing LVEF, such as transthoracic echocardiography (TTE), are effective but may not always be readily available or feasible in certain clinical settings. A study published in the Lancet did a deep-dive into Artificial Intelligence for detecting LVEF.

The study under discussion presents a novel approach utilizing AI-enabled electrocardiogram (ECG) for the detection of reduced LVEF (≤40%). Conducted across multiple healthcare sites, the study enrolled a cohort of patients undergoing TTE, with ECG recordings obtained simultaneously using an ECG-enabled stethoscope. The primary objective was to evaluate the performance of AI-ECG in accurately classifying patients based on their LVEF status.  

The AI algorithm demonstrated high sensitivity and specificity, particularly when ECG recordings were obtained over specific precordial positions. The area under the receiver operating characteristic curve (AUROC) for the best-performing position exceeded 0.85, indicating excellent discriminatory ability. Logistic regression modeling showed substantial improvement in predictive accuracy, highlighting the potential of advanced statistical techniques in refining diagnostic algorithms.

By integrating AI into routine clinical practice via ECG-enabled devices, clinicians can expedite the identification of patients at risk of reduced LVEF, facilitating early intervention and risk stratification. This approach holds particular promise in primary care settings, where access to specialized cardiac imaging may be limited, yet the need for timely diagnosis remains paramount. AI-enabled ECG not only offers a non-invasive and cost-effective means of LVEF assessment but also streamlines workflow and enhances patient care delivery. 

The study represents a significant advancement in the field of cardiovascular medicine, demonstrating the feasibility and efficacy of AI-enabled ECG for detecting reduced LVEF. By harnessing the power of AI, clinicians can harness an innovative tool to enhance the detection and management of heart failure, ultimately improving patient outcomes and reducing healthcare disparities. 

Sources: Lancet  

About the Author
Doctor of Pharmacy (PharmD)
Greta holds her PharmD and is a writer at Labroots. She also has a strong background in neuroscience & psychology. When she is not working as a pharmacist or a writer, she enjoys fostering her creative initiatives such as traveling, working out, spending time at the beach, and cooking!
You May Also Like
Loading Comments...